2021 annual financial data
Dogwood Therapeutics 2021 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -15,640,940 USD and net income was -15,960,268 USD.
Operating cash flow was -15,689,578 USD.
Get free Dogwood Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -15,640,940 USD
- Net income
- -15,960,268 USD
- Operating cash flow
- -15,689,578 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Dogwood Therapeutics financial years